Blonder Tongue Laboratories, Inc. (BDRL)
OTCMKTS: BDRL · Delayed Price · USD
0.0912
0.00 (0.00%)
Jun 10, 2024, 9:33 AM EDT - Market open

BDRL Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 20222021202020192018 2017 - 1994
Net Income
-2.920.08-7.47-0.74-1.34
Upgrade
Depreciation & Amortization
0.891.141.11.110.52
Upgrade
Share-Based Compensation
0.550.730.40.710.49
Upgrade
Other Operating Activities
0.1-3.122.76-7.610.91
Upgrade
Operating Cash Flow
-1.38-1.17-3.21-6.540.59
Upgrade
Capital Expenditures
-0.05-0.03-0.179.53-0.08
Upgrade
Other Investing Activities
-0.01-0.06-0.03-0.05-0.02
Upgrade
Investing Cash Flow
-0.06-0.09-0.199.47-0.1
Upgrade
Share Issuance / Repurchase
00.560.830.010.04
Upgrade
Debt Issued / Paid
1.240.892.08-2.93-0.14
Upgrade
Financing Cash Flow
1.241.462.9-2.92-0.1
Upgrade
Net Cash Flow
-0.20.21-0.50.010.39
Upgrade
Free Cash Flow
-1.43-1.2-3.382.990.51
Upgrade
Free Cash Flow Growth
---490.71%-
Upgrade
Free Cash Flow Margin
-7.89%-7.60%-20.62%15.06%2.33%
Upgrade
Free Cash Flow Per Share
-0.11-0.10-0.340.310.06
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).